From Our Writers

The medical cannabis advocacy group Americans for Safe Access has released its annual “State of the States” report, which grades the states on their medical cannabis access options, and zero U.S. states or territories received an “A” from the organization.

Argentina has established a new federal agency to regulate the nation’s hemp and medical cannabis industries.

A Virginia House panel voted down two bills this week that sought to establish regulations for retail cannabis sales in the state.

The head of Oregon’s cannabis and alcohol regulatory agency is stepping down per the governor’s request after nearly 10 years in the position.

Lawmakers in the North Dakota House this week rejected two proposals to allow infused edibles in the state’s medical cannabis program.

The cannabis B2B tech firm LeafLink announced it raised $100 million in its Series D financing round.

U.S. Rep. Greg Steube (R-FL) has introduced a proposal to reschedule cannabis from Schedule I to Schedule III under the Controlled Substances Act.

California cannabis regulators last week asked the state attorney general’s office whether they could allow interstate cannabis commerce without sparking federal enforcement.

The head of a Washington, D.C. cannabis delivery company pleaded guilty this week to federal money laundering charges related to about $3.5 million worth of unregulated cannabis sales.

The state of Pennsylvania has awarded $200,000 in grants to three agriculture nonprofits heading projects related to industrial hemp-based fiber and food products.

Researchers at Australia’s University of Sydney have launched the world’s first-ever study investigating the efficacy of CBD treatments for spinal cord injury-induced chronic pain.

A bipartisan Pennsylvania proposal would allow doctors to certify patients for the state’s medical cannabis program for any condition that they believe could benefit from cannabis therapy.

Massachusetts’ total cannabis sales since the state’s 2018 launch of the adult-use marketplace have now surpassed $4 billion.

Washington lawmakers are considering bills to allow cannabis home grows and end the practice of drug testing for cannabis as a condition for getting hired.

Wyoming’s House Education Committee has tabled a bill carrying penalties for selling synthetically derived cannabinoid products to minors.

The FDA will not regulate CBD products as dietary supplements but the agency said it would “work with Congress” to establish rules for hemp-derived cannabinoid products, which are federally legal but remain unregulated.

For the first time ever, a Minnesota Senate committee heard testimony this week related to a cannabis legalization proposal — similar bills have passed the House but were blocked in the formerly Republican-controlled Senate.

Northwest Missouri State University is partnering with cannabis education company Green Flower for a cannabis certificate program covering cannabis-related science and business.

A new report found cannabis legalization does not lead to an increase in substance use disorders or the increased use of illicit drugs.

Medical cannabis sales have launched in Mississippi, nearly a year after the reforms were signed into law.

New York’s Committee on Open Government said the state’s Office of Cannabis Management has not been following the state open meeting laws.

The FDA released its proposed final guidance for research related to developing drugs containing cannabis or cannabis-derived compounds.

A real estate developer has filed suit against the city of Pontiac, Michigan and its clerk over the delayed enactment of local cannabis industry rules.

Manhattan’s LIM College is partnering with the Association of Cannabis Workers (ACW) Local Union 420 to offer a four-week, online Cannabis Industry Fundamentals course.